Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MNTA > SEC Filings for MNTA > Form 8-K on 21-Feb-2014All Recent SEC Filings

Show all filings for MOMENTA PHARMACEUTICALS INC

Form 8-K for MOMENTA PHARMACEUTICALS INC


21-Feb-2014

Change in Directors or Principal Officers, Financial Statements and E


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e)

On February 18, 2014, the Compensation Committee of the Board of Directors of Momenta Pharmaceuticals, Inc., a Delaware corporation (the "Company"), approved the following grants of options to purchase shares of the Company's common stock, $0.0001 par value per share (the "Common Stock"), and awards of restricted Common Stock relating to performance during the fiscal year ended December 31, 2013 for the executive officers of the Company listed below:

                          Shares Underlying      Shares of
Name                        Stock Options     Restricted Stock
   Craig A. Wheeler                 150,000             60,000
    Richard P. Shea                  38,575             19,312
Ganesh Kaundinya, Ph.D.              38,575             19,312
 James M. Roach, M.D.                40,504             20,278
   Bruce A. Leicher                  40,504             20,278

The stock option grants set forth above were made under the Company's 2013 Incentive Award Plan (the "2013 Stock Plan"), under the following terms: (i) an exercise price equal to the last reported sale price of the Common Stock on the date of grant, or $17.96 per share, (ii) a ten year duration and (iii) vesting quarterly over the four-year period following the date of grant, provided that the optionee has a continuous relationship with the Company. The shares of restricted Common Stock set forth above were also awarded under the 2013 Stock Plan. Twenty-five percent of the shares of restricted Common Stock subject to such awards shall vest on February 18, 2015 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three-month period thereafter. The Company's form of Incentive Stock Option Agreement was filed as Exhibit 10.1 to the Company's Current Report on Form 8-K on June 13, 2013 and is incorporated herein by reference. The Company's form of Restricted Stock Agreement was filed as Exhibit 10.2 to the Company's Current Report on Form 8-K filed on June 13, 2013 and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.                                  Description

10.1           Form of Incentive Stock Option Agreement (Filed as Exhibit 10.1 to the
               Company's Current Report on Form 8-K on June 13, 2013, Commission File
               No. 0-50797, is incorporated herein by reference).

10.2           Form of Restricted Stock Agreement (Filed as Exhibit 10.2 to the
               Company's Current Report on Form 8-K on June 13, 2013 Commission File
               No. 0-50797, is incorporated herein by reference).


  Add MNTA to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MNTA - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.